Clinical responses and relapses in omalizumab-assisted desensitization to food in children: long-term evolution in real life
Desensitization (DSZ) or oral tolerance induction is increasingly used in children who do not outgrow their food allergies. Off-label omalizumab (OMZ) is used as adjuvant therapy for those with severe reactions, but there is little information on outcomes when OMZ is withdrawn. The long-term outcome...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Open Exploration Publishing Inc.
2024-01-01
|
| シリーズ: | Exploration of Asthma & Allergy |
| 主題: | |
| オンライン･アクセス: | https://www.explorationpub.com/uploads/Article/A100925/100925.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|